Cargando…
1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
BACKGROUND: The COVID 19 disease has claimed over 6.3 million lives, globally. Despite such high casualties, the treatment options are limited. Although the FDA issued emergency use authorizations for oral antivirals to treat mild-to-moderate COVID 19 disease, intravenous Remdesivir treatment remain...
Autores principales: | Jeyapalina, Sujee, Lundquist, Margaret, Wei, Guo, Stoddard, Gregory, Agarwal, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751993/ http://dx.doi.org/10.1093/ofid/ofac492.966 |
Ejemplares similares
-
407. Prevalence of Post-COVID Sequelae Amongst Fully Vaccinated and Unvaccinated US Hospitalized Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2023) -
Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans–A potential marker for disease severity
por: Jeyapalina, Sujee, et al.
Publicado: (2023) -
Hospitalization, mechanical ventilation, and case-fatality outcomes in US veterans with COVID-19 disease between years 2020–2021
por: Luo, Jessica, et al.
Publicado: (2022) -
Coronavirus disease 2019 in veterans receiving care at veterans health administration facilities
por: Luo, Jessica, et al.
Publicado: (2021) -
QS8: Analysis of the Whole Transcriptome in Breast Cancer Patients Undergoing Radiotherapy and Breast Reconstruction
por: Miller, Andrew, et al.
Publicado: (2021)